Private Advisor Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,945
Closed -$319K 2824
2025
Q4
$319K Buy
+1,945
New +$305K ﹤0.01% 2119
2022
Q1
Sell
-2,339
Closed -$620K 2250
2021
Q4
$620K Sell
2,339
-234
-9% -$63K ﹤0.01% 1339
2021
Q3
$744K Buy
+2,573
New +$660K ﹤0.01% 1341
2021
Q2
Sell
-7,503
Closed -$1.46M 2030
2021
Q1
$1.46M Buy
+7,503
New +$1.54M 0.01% 835
2020
Q3
Sell
-400
Closed -$49K 3024
2020
Q2
$49K Buy
+400
New +$47.1K ﹤0.01% 2116

Other funds holding RGEN

Private Advisor Group's RGEN Position: Q1 2026 in Review

Private Advisor Group sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,945 shares — an estimated $319K sold.

Private Advisor Group first reported a position in RGEN in Q2 2020 and held it in 5 quarters. The position peaked at $1.46M in Q1 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Private Advisor Group reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Private Advisor Group sold 1,945 Repligen shares in Q1 2026, an estimated $319K.
  • Private Advisor Group first reported a position in Repligen in Q2 2020 and held it in 5 quarters.
  • Private Advisor Group's Repligen position peaked at $1.46M in Q1 2021.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.